• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性主动脉夹层及其他主动脉综合征的生物标志物。

Biomarkers in acute aortic dissection and other aortic syndromes.

机构信息

School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom.

出版信息

J Am Coll Cardiol. 2010 Nov 2;56(19):1535-41. doi: 10.1016/j.jacc.2010.01.076.

DOI:10.1016/j.jacc.2010.01.076
PMID:21029872
Abstract

Acute aortic syndromes have an incidence of >30 per million per annum and a high mortality without definitive treatment. Survival may relate to the speed of diagnosis. Although pain is the most common symptom, there is a large fraction of patients in whom the diagnosis may be mistaken or overlooked. Currently, a high index of clinical suspicion is the chief prompt that diverts a patient into a definitive algorithm of imaging investigations. Although there is no point-of-care biochemical test that can be reliably used to positively identify dissection, biomarkers are available that could accelerate the diagnostic pathway and thereby expedite treatment.

摘要

急性主动脉综合征的年发病率超过每百万分之 30,若不进行明确治疗,死亡率很高。及时诊断可能与生存率相关。尽管疼痛是最常见的症状,但仍有很大一部分患者的诊断可能被误诊或忽视。目前,高度的临床怀疑是促使患者进入明确影像学检查算法的主要因素。虽然没有即时的生化检测可以可靠地用于明确诊断夹层,但生物标志物可用于加速诊断过程,从而加快治疗速度。

相似文献

1
Biomarkers in acute aortic dissection and other aortic syndromes.急性主动脉夹层及其他主动脉综合征的生物标志物。
J Am Coll Cardiol. 2010 Nov 2;56(19):1535-41. doi: 10.1016/j.jacc.2010.01.076.
2
Acute aortic dissection: the need for rapid, accurate, and readily available diagnostic strategies.
Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1721-3. doi: 10.1161/01.ATV.0000093222.33222.D2.
3
[Increased serum concentration of myosin heavy chain in aortic dissection: discussion of 2 cases].
Z Kardiol. 1997 Jun;86(6):469-73. doi: 10.1007/s003920050081.
4
Aortic dissection--in pursuit of a serum marker.主动脉夹层——寻找血清标志物
Am J Emerg Med. 2008 Oct;26(8):942-5. doi: 10.1016/j.ajem.2007.12.012.
5
Biomarker-assisted diagnosis of acute aortic dissection: how far we have come and what to expect.生物标志物辅助急性主动脉夹层诊断:我们已经走了多远,以及未来的期望。
Curr Opin Cardiol. 2010 Nov;25(6):541-5. doi: 10.1097/HCO.0b013e32833e6e13.
6
Letter by Hugli regarding article, "Diagnosis of acute aortic dissection by D-dimer: the International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience".胡格利就“通过D-二聚体诊断急性主动脉夹层:急性主动脉夹层生物标志物国际注册研究(IRAD-Bio)经验”一文所写的信。
Circulation. 2010 Feb 2;121(4):e23; author reply e24. doi: 10.1161/CIR.0b013e3181cf2db5.
7
Biomarkers for diagnosis and prognostic stratification of aortic dissection: challenges and perspectives.用于主动脉夹层诊断和预后分层的生物标志物:挑战与展望。
Biomark Med. 2014;8(7):931-41. doi: 10.2217/bmm.14.38.
8
Implications of pentraxin 3 levels in patients with acute aortic dissection.急性主动脉夹层患者中五聚体3水平的意义
Heart Vessels. 2015 Mar;30(2):211-7. doi: 10.1007/s00380-014-0470-2. Epub 2014 Jan 29.
9
Preliminary study of serum tenascin-C levels as a diagnostic or prognostic biomarker of type B acute aortic dissection.血清腱生蛋白-C水平作为B型急性主动脉夹层诊断或预后生物标志物的初步研究
Int J Cardiol. 2013 Oct 9;168(4):4267-9. doi: 10.1016/j.ijcard.2013.04.211. Epub 2013 Jun 3.
10
Letter to the Editor: Admission Values of Plasma Biomarkers Predict the Short-Term Outcomes in Acute Aortic Dissection.给编辑的信:血浆生物标志物的入院值可预测急性主动脉夹层的短期预后。
Heart Surg Forum. 2021 Apr 23;24(2):E375. doi: 10.1532/hsf.3761.

引用本文的文献

1
The Reduction of COMP Serves as a Predictor for Warning of Aortic Dissection Progression.COMP的降低可作为主动脉夹层进展预警的预测指标。
JACC Basic Transl Sci. 2025 Jul 17;10(8):101329. doi: 10.1016/j.jacbts.2025.101329.
2
Development and Validation of a Diagnostic Model for Stanford Type B Aortic Dissection Based on Proteomic Profiling.基于蛋白质组学分析的 Stanford B 型主动脉夹层诊断模型的开发与验证
J Inflamm Res. 2025 Jan 10;18:533-547. doi: 10.2147/JIR.S494191. eCollection 2025.
3
Smooth Muscle Myosin Heavy Chain Expression in Nodal and Extranodal Follicular Dendritic Cell Sarcoma.
结内和结外滤泡树突状细胞肉瘤中平滑肌肌球蛋白重链的表达
Appl Immunohistochem Mol Morphol. 2025 Mar 1;33(2):103-110. doi: 10.1097/PAI.0000000000001241. Epub 2025 Jan 9.
4
Yes-associated protein-based detection of acute type A aortic dissection and evaluation of therapeutic responses.基于Yes相关蛋白检测急性A型主动脉夹层及评估治疗反应
Front Cardiovasc Med. 2024 Dec 23;11:1432007. doi: 10.3389/fcvm.2024.1432007. eCollection 2024.
5
The combined use of serum Raman spectroscopy and D dimer testing for the early diagnosis of acute aortic dissection.血清拉曼光谱与D-二聚体检测联合用于急性主动脉夹层的早期诊断
Heliyon. 2024 Jun 5;10(12):e32474. doi: 10.1016/j.heliyon.2024.e32474. eCollection 2024 Jun 30.
6
Soluble ST2: A Novel Biomarker for Diagnosis and Prognosis of Cardiovascular Disease.可溶性 ST2:心血管疾病诊断和预后的新型生物标志物。
Curr Med Sci. 2024 Aug;44(4):669-679. doi: 10.1007/s11596-024-2907-x. Epub 2024 Aug 3.
7
The role of oxidative stress in aortic dissection: a potential therapeutic target.氧化应激在主动脉夹层中的作用:一个潜在的治疗靶点。
Front Cardiovasc Med. 2024 Jul 12;11:1410477. doi: 10.3389/fcvm.2024.1410477. eCollection 2024.
8
Progress and perspectives of metabolic biomarkers in human aortic dissection.人类主动脉夹层中代谢生物标志物的研究进展与展望
Metabolomics. 2024 Jul 13;20(4):76. doi: 10.1007/s11306-024-02140-z.
9
Incidence, presentation and outcome of acute aortic dissection: results from a population-based study.急性主动脉夹层的发病率、表现和转归:一项基于人群的研究结果。
Open Heart. 2024 Mar 13;11(1):e002595. doi: 10.1136/openhrt-2023-002595.
10
Diagnostic biomarkers and aortic dissection: a systematic review and meta-analysis.诊断生物标志物与主动脉夹层:系统评价和荟萃分析。
BMC Cardiovasc Disord. 2023 Oct 10;23(1):497. doi: 10.1186/s12872-023-03448-9.